Akturk Halis K, Rompicherla Saketh, Rioles Nicole, Desimone Marisa, Weinstock Ruth S, Haw Sonya J, Ziemer David C, Dickinson Jane K, Agarwal Shivani, Ebekozien Osagie, Polsky Sarit
Barbara Davis Center, Denver, CO.
T1D Exchange, Boston, MA.
Clin Diabetes. 2022 Winter;41(1):76-80. doi: 10.2337/cd22-0067. Epub 2022 Oct 17.
Many adults with diabetes do not reach optimal glycemic targets, and, despite advances in diabetes management, diabetes technology use remains significantly lower in racial/ethnic minority groups. This study aimed to identify factors associated with achieving the recommended A1C target of <7% using data on 12,035 adults with type 1 diabetes from 15 centers participating in the T1D Exchange Quality Improvement Collaborative. Individuals attaining the target A1C were more likely to be older, White, have private health insurance, and use diabetes technology and less likely to report depressive symptoms or episodes of severe hypoglycemia or diabetic ketoacidosis than those with higher A1C levels. These findings highlight the importance of overcoming inequities in diabetes care.
许多成年糖尿病患者未达到最佳血糖目标,而且,尽管糖尿病管理取得了进展,但种族/族裔少数群体的糖尿病技术使用率仍然显著较低。本研究旨在利用来自参与T1D交换质量改进协作项目的15个中心的12,035名1型糖尿病成年患者的数据,确定与实现推荐的糖化血红蛋白(A1C)目标<7%相关的因素。与A1C水平较高的患者相比,达到目标A1C的个体更可能年龄较大、为白人、拥有私人医疗保险并使用糖尿病技术,且报告抑郁症状、严重低血糖发作或糖尿病酮症酸中毒的可能性较小。这些发现凸显了克服糖尿病护理不平等现象的重要性。